The combined AFP+CA19-9+CEA or AFP+CA19-9 or AFP+CEA although have low sensitivity, it high specificity makes it a better marker to rule out HCC when patients test, making it a potential definitive and differential diagnostic combined marker. Here, CEACAM5 is linked to hepatocellular carcinoma.